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Venous thromboembolism, manifested as deep
venous thrombosis (DVT) or pulmonary emboliza-
tion, is a significant clinical problem. Acute DVT is
responsible for more than 600,000 hospitalizations
each year and a 1-year mortality rate of 21%.1-4
Because of its accuracy and noninvasive characteris-
tics, duplex ultrasound scanning has become the
diagnostic test of choice for the detection of DVT.
Although venography historically was performed
only on the symptomatic leg, ultrasound scan exam-
inations routinely have been performed on both legs
because of easy patient acceptance and the finding
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Purpose: Recent studies have recommended unilateral venous duplex scanning for the
diagnosis of deep venous thrombosis (DVT) in patients who are unilaterally sympto-
matic. Vascular laboratory accreditation standards, however, imply that bilateral leg
scanning should be performed. We examined whether actual practice patterns have
evolved toward limited unilateral scanning in such patients.
Methods: A questionnaire was mailed to all 808 vascular laboratories in the United States
that were accredited by the Intersocietal Commission for the Accreditation of Vascular
Laboratories (ICAVL). To encourage candid responses, the questionnaires were numer-
ically coded and confidentiality was assured.
Results: A total of 608 questionnaires (75%) were completed and returned. Most of the
respondents (442; 73%) were either community-hospital or office-based laboratories, and
the remaining 163 (27%) were university or affiliated-hospital laboratories. Most of the
laboratories (460; 76%) had been in existence for 9 years or more, and 65% had been
ICAVL–accredited in venous studies for 3 years or more. Board-certified vascular surgeons
were the medical directors in 54% of the laboratories. Duplex ultrasound scanning was the
diagnostic method used by 98% of the laboratories. In patients with unilateral symptoms,
75% of the laboratories did not routinely scan both legs for DVT. A large majority (75%)
believe that bilateral scanning is not clinically indicated. Only 57 laboratories (14%)
recalled having patients return with a DVT in the previously unscanned leg, with 93% of
these laboratories reporting between one and five such patients. This observation corre-
lated with larger volumes of venous studies performed by those laboratories (P < .05).
Similarly, only 52 laboratories (12%) recalled having patients return with subsequent pul-
monary emboli. Of these laboratories, only five reported proximal DVT in the previously
unscanned legs of such patients. Of all these laboratories, therefore, only 1% (5 of 443)
have potentially missed the diagnosis of a DVT that caused a preventable pulmonary
embolus with such a policy. Among those laboratories that always perform bilateral exam-
inations, 41% do so because of habit. Most (61%) of the laboratories that perform bilater-
al scanning would do unilateral scanning if it were specifically approved by ICAVL.
Conclusion: Three quarters of the ICAVL–accredited vascular laboratories perform lim-
ited single-extremity scanning for the diagnosis of DVT in patients with unilateral symp-
toms. This broad clinical experience suggests that this practice is widespread in selected
patients. Clinical protocols should be established to provide guidelines for local labora-
tory implementation. (J Vasc Surg 1999;29:799-806.)
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that there was a high incidence rate of unsuspected
thrombi in the contralateral limb.3,5,6 More recently,
however, studies have shown that contralateral
thrombi were rarely of any clinical significance.7-9 It
has been proposed that, in patients with unilateral
symptoms, only the symptomatic extremity should
initially undergo examination.7-10 This study was
performed to investigate the actual practice patterns
in the noninvasive diagnosis of DVT in the United
States in regards to bilateral versus unilateral duplex
scanning.
MATERIALS AND METHODS
A one-page, multiple-choice questionnaire
(Appendix) was mailed on December 15, 1997, to
all the vascular laboratories that were accredited by
the Intersocietal Commission for the Accreditation
of Vascular Laboratories (ICAVL). The question-
naires were numbered sequentially to ascertain those
responding and to assure confidentiality. A follow-
up request was sent to the nonresponders at 2 weeks
and again at 1 month after the initial mailing. The
answers to the questions were compiled and ana-
lyzed in a blinded fashion. Some responders did not
provide an answer to all the questions.
The responses on the completed questionnaires
were entered into a relational database (Approach 3.0,
Lotus Corp, Boston, Mass). The data subsequently
were analyzed with Excel 95 software (Microsoft,
Redmond, Wash). The data are expressed as the mean
± the standard error of the mean. Statistical analysis
was performed with the SigmaStat statistical program
(Jandel Scientific, San Rafael, Calif). The Mann-
Whitney test or the t test were used for continuous
data, and the Fisher exact test or the c 2 test were used
for dichotomous data. A P value of less than .05 was
considered to be statistically significant.
RESULTS
Of the 822 laboratories that were accredited by
the ICAVL at the time of the study, 808 were within
the United States, six were located in Puerto Rico,
and eight were in Canada. Of those in the United
States, 608 (75%) returned a completed question-
naire. These laboratories form the basis of this report.
The geographic distribution was nearly evenly divid-
ed between the south, the midwest, and the east
regions of the country (Table I). The most respons-
es were from Pennsylvania (53; 9%), New York (44;
7%), Ohio (40; 7%), and California (38; 6%). This
regional and state distribution mirrored the distribu-
tion of accredited laboratories reflecting a representa-
tive response to the questionnaire. Most of the
respondents [442; 73%] were either community-hos-
pital or office-based laboratories and the remaining
163 (27%) were university or university-affiliated
teaching hospital laboratories (Table II). Most labo-
ratories (460; 76%) had been in existence for 9 years
or more. A total of 87% of the laboratories had been
ICAVL–accredited in venous studies for 1 year or
more, and 65% (376 of 577) had been accredited for
3 years or more.
Most of the laboratories were busy, with 54%
(321 of 594) performing more than 2000 total year-
ly vascular examinations and only 19% (116) per-
forming less than 1000 studies. The number of
examinations performed specifically for the diagno-
sis of acute lower extremity DVT exceeded 500 cases
per year for 57% of the laboratories (334 of 590),
while 18% performed less than 250 studies each year.
Of these studies, 20% or less were performed as an
emergency after-hours procedure in 87% (500 of
576) of the laboratories. Duplex ultrasound scan-
ning was the predominant method (98%; 582 of
593) that was used for the noninvasive diagnosis of
DVT. Board-certified vascular surgeons were the
medical directors in more than half of the laborato-
ries surveyed (Table III). Almost half of the labora-
tories (49%; 289 of 589) had only one or two full-
time vascular technologists employed, and 16% had
five or more.
In patients who were symptomatic with unilater-
al leg symptoms, 75% of vascular laboratories (443
of 590) did not routinely scan both legs for DVT.
Laboratories that performed unilateral scans were
larger, with 32% (139 of 431) having four or more
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Table I. Geographic distribution of responses
Region No. of responses (%)
South 177 (29%)
Midwest 173 (29%)
East 164 (27%)
West 90 (15%)
Unidentified 4 (<1%)
TOTAL 608
Table II. Laboratory location
Location No. of responses (%)
Community hospital 262 (43%)
Private office 180 (30%)
University-affiliated teaching hospital 95 (16%)
University hospital 68 (11%)
Mobile laboratory 3 (<1%)
vascular technologists as compared with only 21%
(33 of 158) among those performing bilateral scan-
ning (P < .01). Associated with this observation, the
laboratories that always performed bilateral scans did
a lesser total number of vascular examinations, with
27% (42 of 158) performing less than 1000 per year.
Only 17% (74 of 436) of unilateral scanning labora-
tories did such a low number of examinations (P =
.01). There were no significant differences between
the laboratories that performed bilateral or unilater-
al studies when examined in terms of the region of
the country (Table I), the location of the laboratory
(Table II), the specialty of the medical director, or
the number of years that the laboratory had been in
existence or had had ICAVL accreditation in venous
studies.
Most of the laboratories (68%; 292 of 429) that
performed unilateral scanning did so more than half
of the time (Table IV). The decision for unilateral
examination was made most frequently by the refer-
ring physician (Table V). More than half of the lab-
oratories (59%; 254 of 428) had a written protocol
or criteria for patient selection in determining which
ones should undergo unilateral scanning. The prin-
cipal reasons quoted for unilateral scanning were a
belief that bilateral scanning was not clinically indi-
cated (75%; 315 of 420)—that it was more cost
effective (14%; 59)—or for research purposes (11%).
Three quarters of these laboratories have performed
unilateral scanning for more than 5 years (74%; 306
of 416).
Only 14% of the laboratories (57 of 394) recalled
having any patient return with an acute proximal
DVT in the previously asymptomatic unscanned leg
within 1 month of the unilateral examination. Most
of these laboratories (93%; 53 of 59) reported
between one and five such patients. The subsequent
detection of contralateral DVT correlated with larg-
er volumes of venous studies performed by those
laboratories (P < .05). Similarly, 15% of the labora-
tories (52 of 362) recalled having patients return
with subsequent pulmonary emboli (PE) within 1
month of the unilateral duplex scanning of the lower
extremity. Of these laboratories, only five reported a
proximal DVT in the previously unscanned con-
tralateral limb of such patients. Of all the laborato-
ries that performed unilateral scanning, therefore,
only 1% (5 of 443) have potentially missed the diag-
nosis of a DVT that may have been associated with a
preventable PE with such a policy.
Of the 25% of the laboratories (147 of 590) that
always performed bilateral examinations in patients
who were symptomatic with only unilateral leg
symptoms, 41% did so because they have always
done it that way, 57% believe that it is dangerous to
only scan one side, 6% fear litigation, and 3% do so
for research purposes. Most of the laboratories
(61%) that currently perform bilateral lower extrem-
ity venous scanning would perform unilateral scan-
ning if specifically approved by ICAVL.
DISCUSSION
To prevent thrombus extension and pulmonary
embolization, early and accurate diagnosis of DVT is
necessary for the timely initiation of anticoagulation
therapy. Signs and symptoms suggestive of DVT are
inadequate, and, even when highly suspected, DVT
is confirmed only 25% of the time.11 Venous duplex
scanning combines the advantages of a totally non-
invasive, relatively inexpensive method with a sensi-
tivity of up to 93% and a specificity of 98% in the
diagnosis of DVT.5,12 Clinician acceptance of this
diagnostic technique has been so encompassing that
it has been questioned whether the threshold for
duplex scanning use has been lowered too far
because so few of the examinations confirm the pres-
ence of DVT.13
Before the availability of ultrasound scan imag-
ing, venography had only been performed on the
symptomatic leg because of its invasiveness and the
development of subsequent phlebitis in a small num-
ber of patients. Examinations limited to the sympto-
matic limb during that time period do not appear to
have been associated with clinically inadequate treat-
ment of patients with venous thrombosis. The intro-
duction of noninvasive ultrasound scan methodolo-
gy allowed both legs to be scanned without any
additional risks to the patient. This also provided the
opportunity to compare the findings on one side
with the contralateral limb. Such routine bilateral
examinations uncovered a high incidence rate of
contralateral DVT, even in limbs that were com-
pletely asymptomatic, that ranged from 17% to
32%.3,5,6,11 During this same time period, the wide-
spread acceptance of noninvasive vascular diagnostic
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Table III. Laboratory medical director
Specialties No. of responses (%)
Vascular surgeon 336 (54%)
Radiologist 130 (21%)
Surgeon 84 (13%)
Internal medicine/cardiology 48 (8%)
Neurologist 18 (3%)
Other 9 (1%)
TOTAL 625
studies and associated proliferation of vascular labo-
ratories led to the formation of the ICAVL. With the
objectives of encouraging and documenting compe-
tency in vascular studies, ICAVL accreditation was
sought by many laboratories. The requirements for
accreditation in venous duplex ultrasound scanning
defined a complete study as one that included both
lower extremities.14 The high prevalence of bilater-
ality in lower extremity DVT, in association with
accreditation requirements, contributed to the per-
ception that bilateral venous scanning should be
routinely performed.12,6,12
The initial studies that documented a high inci-
dence rate of bilateral DVT, however, did not sepa-
rately examine the subgroup of patients who were
symptomatic nor define the acuity of the unsuspected
contralateral DVT in individual patients to determine
whether such findings would have affected patient
management. Because anticoagulation therapy is sys-
temic, the contralateral DVT would be treated just as
effectively as the identified thrombus. To examine the
clinical relevance of the contralateral limb in patients
who were unilaterally symptomatic, we previously
reported on our experience with 2530 patients.7,9
Although we found bilateral DVT in 28% of these
patients, no patient with a normal symptomatic side
had contralateral proximal acute DVT. Contralateral
DVT occurred only in the presence of an abnormali-
ty in the symptomatic leg. Therefore, no patient
would have been denied appropriate clinical treat-
ment if only unilateral venous scanning would have
been done. In addition, we found that a unilateral
ultrasound scan study decreased the total scanning
time by 21% and had the potential of increasing reim-
bursement by approximately 9%.7 We concluded that
unilateral scanning should be the technique of choice
in patients who were symptomatic. Several other stud-
ies, which total 1709 patients, also support this view-
point that clinical patient management would not be
deleteriously affected if unilateral studies were per-
formed in these circumstances.8,10,15,16
With an overall 75% response rate that was even-
ly distributed from all regions of the country and all
types of vascular laboratories, our survey is fairly rep-
resentative of national practice patterns in the United
States today for the ultrasound scan diagnosis of
DVT. A large number of university and university-
affiliated hospital laboratories responded, but most
were community-hospital or office-based laboratories
(Table II). Reflecting the qualities necessary to suc-
cessfully attain ICAVL accreditation, most laborato-
ries have been in existence for 9 years or more. The
laboratories were fairly busy, with more than half of
them performing more than 2000 total vascular
studies each year and more than 500 duplex ultra-
sound scans for the diagnosis of DVT. Emphasizing
the extensive nationwide replacement of indirect
physiologic techniques, fully 98% of the laboratories
used duplex scanning as the method of choice in
DVT diagnosis. The results from this survey confirm
that there is widespread implementation of unilateral
scanning in patients who are symptomatic in only
one leg. Fully 75% of all the surveyed vascular labo-
ratories do not routinely examine both legs in this sit-
uation. Two thirds perform unilateral scanning more
than half the time (Table IV). Although laboratories
that performed unilateral scanning were larger
(employing more technologists) and the laboratories
that always performed bilateral scanning did a small-
er total number of vascular examinations each year,
there was otherwise an even distribution across all
laboratory types in the performance of unilateral
scanning. There were no differences between univer-
sity and community-hospital/private laboratories,
regions of the country, specialty of the medical direc-
tor, or the number of years that the laboratory had
been in existence or had had ICAVL accreditation in
venous studies.
Consistent with the results from published stud-
ies, three quarters of the laboratories that performed
unilateral scanning believed that bilateral examina-
tions were not clinically indicated and 14% believed
that it was more cost effective to perform unilateral
examinations. Interestingly, most of these laborato-
ries have been performing unilateral scanning for
more than 5 years. This would antedate all of the
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Table V. Decision maker on unilateral scanning
Decision maker No. of responses (%)
Referring physician 280 (63%)
Vascular technologist 179 (40%)
Medical laboratory director 71 (16%)
Laboratory physician 30 (7%)
Combination 104 (23%)
TOTAL 443
Table IV. Frequency of unilateral scanning 
Proportion of studies No. of responses (%)
<25% 82 (19%)
25% to 50% 55 (13%)
51% to 75% 88 (21%)
76% to 99% 165 (39%)
100% 39 (9%)
TOTAL 429
published studies that recommended such a policy.
The survey, however, did not attempt to measure
whether there was an increase in frequency with
which unilateral scanning has been performed that
may have been influenced by the published series.
Usage patterns also appear to have been affected by
referring physicians who were most frequently the
decision makers in determination of a unilateral
examination (Table V). The fact that vascular tech-
nologists made the determination on unilateral scan-
ning 40% of the time presumably reflects the avail-
ability of a written protocol or patient selection cri-
teria in 59% of the laboratories.
There are inherent and acknowledged limitations
to a survey that is made on the basis of the respon-
dents’ memories. Such an instrument cannot accu-
rately report on recurrent DVT or PE nor on
patients who are lost to follow-up. Surveys cannot
define the accuracy of the diagnosis of DVT by indi-
vidual laboratories nor their quality assurance pro-
grams. Nonetheless, it is worthy to note that only
14% of the laboratories recalled seeing patients
return with a contralateral DVT in the unscanned
leg. This is well within the range of bilaterality found
in prior published studies.3,6-9,12,13 The question-
naire did not attempt to question the circumstances
of such events and whether they were of any clinical
significance. Presumably, however, they were not
significant because these laboratories would not
have otherwise been expected to continue with a
protocol of unilateral scanning if the medical direc-
tor had documented recurrent deleterious out-
comes. Along similar lines, 15% of the laboratories
recalled having patients return with PE. However,
on examination in the vascular laboratory, contralat-
eral DVT in the unscanned limbs of these patients
was reportedly found in only five of these 52
instances for an incidence rate of 10%. It is unknown
how many of these patients also had concomitant
symptomatic side DVT. However, to put these
reports in perspective, of all the 443 laboratories that
performed unilateral scanning, there was only a 1%
incidence rate (5 of 443) of potentially missed DVT
that caused preventable PE. In addition, such an
incidence rate, if accurate, is well within the 6%
recurrent thromboembolic event rate for patients
undergoing anticoagulation therapy for DVT.17
Even bilateral scanning is unlikely to prevent all
patients with DVT from having PE. Although the
limitations of such a retrospective survey in this con-
text are recognized, these numbers lend support to
published clinical data that show the safety of unilat-
eral scanning in selected patients.
Among the vascular laboratories that always per-
form bilateral venous scanning, 41% continue to do
so out of habit and most are not yet convinced of the
clinical safety of unilateral examinations. However,
61% would perform unilateral scanning if such a pro-
tocol were specifically approved by ICAVL. The
accrediting body does not prohibit such practices and
recognizes that they “may be appropriate for specific
indications” and suggests that the laboratory “should
have a clinical algorithm” for unilateral examina-
tions.14 They do not, however, elucidate which indi-
cations are appropriate nor what algorithm would be
acceptable. Almost half of the laboratories describe
no written protocols or criteria in place for unilateral
scanning. In the laboratories with such documenta-
tion, it is unknown how precise they are and from
what clinical evidence they are derived. Importantly,
we have noted a wide variability in who makes indi-
vidual patient examination decisions. There is, there-
fore, an obvious need to establish evidence-based
guidelines for local laboratory implementation. We
believe that it would be beneficial and appropriate for
ICAVL to support the development of such labora-
tory guidelines. In our prior reports, we had made
some suggestions describing which symptomatic
patients would be appropriate for unilateral scanning
for the diagnosis of acute DVT.7,9
In summary, we have found that three quarters
of ICAVL–accredited vascular laboratories perform
limited unilateral venous studies in patients who are
symptomatic and have been doing so for a number
of years. Such a broad, under-reported clinical expe-
rience suggests that this practice is widespread in
selected patients. Clinical protocols should be estab-
lished that can provide guidelines for local vascular
laboratory implementation. 
We thank Ms Julie Krall for her technical assistance
during the performance of this survey.
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Dr Ron Savrin (Cleveland, Ohio). This was a fascinat-
ing study, and I think we are all indebted to you at
Hershey for getting and presenting these data.
A look at this abstract prompted me to go back and
look at our own results because we are one of those few
laboratories that continue to do bilateral scanning and I
am not quite sure why. I looked back at our last 1000 con-
secutive patients on whom we performed venous duplex
scanning, and we had an overall incidence rate of deep
venous thrombosis (DVT) of about 12% or 12.5 %, which
is pretty much the normal rate. Fifteen of those 1000
patients had DVT in an asymptomatic limb, and that num-
ber seemed high. Eight of those 15 patients had bilateral
DVT, so those would have been picked up had we done
unilateral scanning. But seven patients had DVT only in
the asymptomatic leg, which was quite a surprise to us.
When we looked at those seven patients, we found that
five of the seven were thought to have pulmonary
embolism. Now, we all understand that this is not the
diagnostic procedure of choice for patients who are sus-
pected of having pulmonary embolism. What I wonder,
on the basis of what you have collected there, with the
data and the kind of information we have, is whether we
should continue to do bilateral scanning in patients in
whom pulmonary embolism is a suspected diagnosis and
whether we should continue to do bilateral scanning in
patients who are at “high risk,” such as those patients who
have long-term periods of time in the intensive care unit
or multiple trauma patients and reserve unilateral scanning
for the rest of the population.
Dr John Blebea. Thank you for your comments. It is an
open question whether initially one should or should not
do lower extremity venous studies for patients who are sus-
pected of having pulmonary embolus (PE) before a venti-
lation-perfusion scan or angiogram. The overall incidence
rate of DVT in this patient group in our prior experience
was only 12%. Our feeling is that there is a role for duplex
scanning of the lower extremities in patients suspected of
PE, but how that fits in with the timing of a ventilation-
perfusion scan or a pulmonary angiogram is debatable. Our
questionnaire, however, excluded such patients. It focused
on patients with unilateral lower extremity symptoms and
did not address patients suspected of having a PE or other
asymptomatic high-risk patient groups.
In reference to your experience with seven patients
and DVT on the contralateral asymptomatic side,
although you did not tell us whether those DVT were
proximal or distal, seven patients out of 1000 is less than
1%. Especially in patients who are asymptomatic, this is
below the sensitivity and specificity duplex scanning. In
addition, five of those seven patients apparently were
referred because of concern for PE, not because they
DISCUSSION
had lower extremity symptoms, and would thus not
have been included in this study.
Dr Sergio X. Salles-Cunha (Toledo, Ohio). I like to
do bilateral studies. It takes only 5 minutes to do
femoral popliteal scanning in the other leg. The reason
is that if a patient has thrombosis on the right leg, most
likely that patient will come back with thrombosis in the
left leg in the future. How will I know if the new throm-
bosis is acute, chronic, or a mixture if I have not
scanned the patient before? Is there any use to know
that that leg was either thrombosed or healthy in the
first event? Is there any use for that information in the
second event?
Dr Blebea. Generally speaking, the answer is no.
Unless you see rather specific clot characterizations to
indicate that it is chronic in nature, even if the patient had
previously undergone scanning, the clinician is probably
still going to treat that patient if he is newly symptomatic.
Even if DVT previously had been documented, most lab-
oratories do not map out the extent of thrombosis to
such a degree that a second episode, if it is not complete-
ly characteristically chronic in appearance, cannot exclude
a new event as superimposed upon acute thrombosis. In
few circumstances will it be of clinical importance that the
asymptomatic leg was not scanned.
Dr Mark Mattos (Springfield, Ill). My question is, can
we afford in today’s litigious society, even to miss one con-
tralateral, proximal, asymptomatic DVT? What is your cut
off for missing clot on the other side? Is it 1%, 10%?
Dr Blebea. That is a good question. We asked people
on the questionnaire why they continued to perform bilat-
eral scanning. Many laboratories do so because they have
always done it that way, but only 6% continue because they
are afraid of potential litigation.
In addition, on the basis of our prior retrospective and
prospective studies, this practice appears to be safe and
efficacious. Even with bilateral scanning, we miss more
than 1% of DVT because duplex ultrasound scanning, no
matter how much we love it, is not 99% accurate no mat-
ter how you do it or who does it. This study also illustrates
that unilateral scanning in patients who are symptomatic is
a widespread practice and that recommendations and cri-
teria should be more clearly established so that legal con-
cerns do not force us to do studies that are not clinically
useful. We should treat patients the way they should be
treated rather than out of fear of litigation.
Please see the related commentary by Hirsch et al on
pages 939-40.
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APPENDIX. Questionnaire
DIAGNOSIS OF LOWER EXTREMITY DEEP VENOUS THROMBOSIS
(Please circle your response)
1. Where is your vascular laboratory located?
University hospital Univ. affiliated teaching hospital Community hospital Private office Mobile
2. How many full-time vascular technologists are employed in your lab?
1 2 3 4 >5
3. How many years has your vascular lab been in existence?
<1 1 - 2 3 - 4 5 - 6 7 - 8 9 - 10 >10
4. How many years has your lab been ICAVL-accredited in venous studies?
<1 1 - 2 3 - 4 5 - 6 7 - 8 9 - 10 >10 years
5. Which best describes your laboratory’s medical director?
Board-certified vascular surgeon Surgeon Radiologist Neurologist Internal medicine/cardiology Other
6. What is the total number of vascular examinations performed by your laboratory each year?
<500 501 - 1000 1001 - 2000 2001 - 3000 3001 - 4000 4001 - 5000 >5000
7. How many examinations each year are done specifically for the diagnosis of acute lower extremity DVT?
<250 251 - 500 501 - 1000 1001 - 1500 1501 - 2000 2001 - 2500 >2500
8. What percentage of these examinations are emergency, after-hours studies?
<10% 11 - 20% 21 - 30% >30%
9. Are all studies to diagnose acute lower extremity DVT performed with duplex sonography? Yes No
If No, what percentage are done with impedance plethysmography?
<25% 25 - 50% 51 - 75% 76 - 99% 100% If 100%, you have completed the survey. Thank you.
10. For the patient with unilateral symptoms do you always scan both legs? If Yes, please go to question 18
Yes No
11. What percentage of patients with only unilateral leg symptoms undergo only a unilateral leg scan?
<25% 25 - 50% 51 - 75% 76 - 99% 100%
12. Do you currently have a written protocol or criteria for patient selection for unilateral scanning? Yes No
13. Who decides whether a unilateral or bilateral duplex examination is performed?
Referring physician Medical director Laboratory physician Vascular technologist
14. What is the principle reason for performing unilateral scanning in patients with unilateral symptoms?
Bilateral scans not clinically indicated More cost effective Research purposes
15. How many patients per year who have had unilateral duplex scans have returned to your hospital within 30 days with acute
proximal contralateral DVT in the previously unscanned leg? None 1 - 5 6 - 10 >10
16. How many patients per year with initially normal unilateral duplex scans have returned to your hospital within 30 days with a
pulmonary embolism (proven by pulmonary angiogram or high-probability V/Q)?
None 1 - 5 6 - 10 >10
If any, did the patient’s previously unscanned leg have a proximal DVT on subsequent duplex exam for PE? Yes No
17. How many years has your laboratory been performing unilateral studies for patients with unilateral symptoms?
<1 1 2 3 4 5 >5
18. (Only for laboratories that always perform bilateral scans) What is your principle reason for always performing bilateral duplex
scanning in patients with unilateral symptoms?
Have always done it this way Dangerous to scan one side only Fear of litigation Research purposes
19. (Only for laboratories that always perform bilateral scans) Would you be willing to perform unilateral scans in symptomatic
patients with unilateral leg symptoms if such a protocol were approved by ICAVL? Yes No
Thank you for your participation!
